Stockscreener 앱 받기
0.3561
4.33%
-0.0161
시간 외 거래:
.33
-0.0261
-7.33%
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals files $73 million lawsuit against tech vendor By Investing.com - Investing.com South Africa
Mangoceuticals Files $73 Million Lawsuit Against Clarity Ventures Over Alleged Contract Breach - geneonline.com
Mangoceuticals Sues Former Tech Partner Over Platform Dispute - TipRanks
Mangoceuticals announces lawsuit seeking damages exceeding $73 million against Clarity Ventures - marketscreener.com
Mangoceuticals files $73 million lawsuit against tech vendor - Investing.com
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures - TradingView
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - The Manila Times
Jacob Cohen option repricing at Mango - TradingView
[8-K] MANGOCEUTICALS, INC. Reports Material Event | MGRX SEC FilingForm 8-K - Stock Titan
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding - GlobeNewswire
Mangoceuticals stock surges on early success of subscription TRT model - MSN
Merger Talk: Is Mangoceuticals Inc stock a top performer YTD2026 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Breakouts: Can Mangoceuticals Inc ride the EV wave2026 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI
Analyst Downgrade: Can Mangoceuticals Inc expand into new marketsEarnings Recap Report & Reliable Volume Spike Alerts - baoquankhu1.vn
Mangoceuticals, Inc. Files International Patent Application for Innovative Antiviral Feed Additive Technology MGX-0024 - Quiver Quantitative
Mangoceuticals, Inc. announces percent patent filing for MGX-0024 antiviral technology to include inhibiting respiratory or orally acquired virus infection in animals or birds - marketscreener.com
Mangoceuticals, Inc. Announces Pct Patent Filing for Mgx-0024 Antiviral Technology - marketscreener.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan
MGRX Earnings History & Surprises | EPS & Revenue Results | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
Aug Closing: Is Mangoceuticals Inc a momentum stockJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
MGRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Institution Moves: Can Mangoceuticals Inc deliver consistent dividendsWeekly Stock Analysis & Community Consensus Trade Signals - baoquankhu1.vn
MGRX Should I Buy - Intellectia AI
Can Mangoceuticals Inc ride the EV waveJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Mangoceuticals reports data on antiviral compound for poultry By Investing.com - Investing.com India
Mangoceuticals' MGX-0024 achieves zero respiratory-related mortality, shows H5N1 prophylactic benefit - marketscreener.com
Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit - TradingView
Mangoceuticals Highlights Promising MGX-0024 Poultry Antiviral Data - TipRanks
Mangoceuticals reports data on antiviral compound for poultry - Investing.com
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study - The Manila Times
Mangoceuticals, Inc. Reports Promising Results for Antiviral Compound MGX-0024 in Poultry Respiratory Disease Management - Quiver Quantitative
Mangoceuticals (MGRX) reports zero respiratory deaths in 29,000 MGX-0024-treated birds - Stock Titan
Mangoceuticals’ Patented MGX-0024 Achieves Zero - GlobeNewswire
Penny Stocks To Follow NowFebruary 21st - MarketBeat
Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX - TechStock²
Penny Stocks To Watch TodayFebruary 20th - MarketBeat
Will Mangoceuticals Inc. stock pay special dividendsJuly 2025 Macro Moves & AI Enhanced Trading Alerts - mfd.ru
These stocks are the most active in today's session - ChartMill
MGRX (Mangoceuticals, Inc., NASDAQ) up 50.75% intraday 20 Feb 2026: TRT sales drive heavy volume - Meyka
Mangoceuticals (MGRX) Stock Surges 70% on TRT Program Growth - parameter.io
How sensitive is Mangoceuticals Inc to inflationPortfolio Value Report & Proven Capital Preservation Methods - baoquankhu1.vn
Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Benzinga
Mangoceuticals stock surges on TRT program growth - Investing.com South Africa
Mangoceuticals stock surges on TRT program growth By Investing.com - Investing.com Canada
Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Benzinga
Mangoceuticals Accelerates Growth With New Testosterone Therapy Program - TipRanks
MangoRx Experiences Initial Success with Newly Launched - GlobeNewswire
Certain Warrants of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-FEB-2026. - marketscreener.com
Certain Common Stock of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-FEB-2026. - marketscreener.com
What’s the profit margin of Mangoceuticals Inc.Portfolio Value Summary & Verified Short-Term Plans - mfd.ru
Will Mangoceuticals Inc. benefit from seasonality2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Is Mangoceuticals Inc. being accumulated by smart moneyMarket Performance Recap & Detailed Earnings Play Alerts - mfd.ru
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Mangoceuticals Inc.’s ROIC above industry averageJuly 2025 Earnings & Weekly High Return Stock Forecasts - mfd.ru
Will Mangoceuticals Inc. stock recover after earningsJuly 2025 Reactions & High Win Rate Trade Tips - mfd.ru
Merger Talk: Does Mangoceuticals Inc have a sustainable dividendJuly 2025 Reactions & Expert Curated Trade Ideas - baoquankhu1.vn
5.94%
자본화:
|
볼륨(24시간):